Leukocytoclastic vasculitis induced by low-dose methotrexate: In vitro evidence for an immunologic mechanism

Sima Halevy, Hani Giryes, Ilana Avinoach, Ella Livni, Shaul Sukenik

    Research output: Contribution to journalArticlepeer-review

    26 Scopus citations

    Abstract

    The rare occurrence of methotrexate (MTX)-induced vasculitis has been associated mainly with high or intermediate MTX doses. We report herein a case of cutaneous leukocytoclastic vasculitis (LCV) following treatment with low-dose oral MTX (7.5 mg/week) for rheumatoid arthritis. The histological findings of a cutaneous lesion were consistent with drug-induced vasculitis. The clinical and histological findings, including the temporal relationship between MTX intake and the onset of vasculitis, and the results of withdrawal and rechallenge tests, suggest a causal relationship, and indicate a drug- induced LCV due to MTX. The role of MTX in the induction of the vasculitis was further supported by a positive mast cell degranulation (MCD) test.

    Original languageEnglish
    Pages (from-to)81-85
    Number of pages5
    JournalJournal of the European Academy of Dermatology and Venereology
    Volume10
    Issue number1
    DOIs
    StatePublished - 27 Feb 1998

    Keywords

    • Leukocytoclastic vasculitis
    • Mast cell degranulation test
    • Methotrexate

    ASJC Scopus subject areas

    • Dermatology
    • Infectious Diseases

    Fingerprint

    Dive into the research topics of 'Leukocytoclastic vasculitis induced by low-dose methotrexate: In vitro evidence for an immunologic mechanism'. Together they form a unique fingerprint.

    Cite this